Uncategorised - European Medical Journal

EMJ

New Way to Treat HER2-Positive Breast Cancer

Scientists at Cold Spring Harbor Laboratory (CSHL) have reported a discovery that they hope will lead to the development of a powerful new way of…

Liver Transplantation For Alcoholic Liver Disease – Time for a Paradigm Shift?

Liver transplantation for alcoholic liver disease (ALD) is controversially discussed. Although overall survival after liver transplantation is similar to…

Use of HBSAG Quantification To Guide HBIG Prophylaxis After Liver Transplantation

Hepatitis B surface antigen (HBsAg) quantification has recently been introduced to guide treatment in chronic hepatitis B virus (HBV) patients.

Cost-Effective Interventions in The Control of Chronic Hepatitis B (CHB) Infection

The hepatitis B virus (HBV) causes infection in the liver that can lead to cirrhosis, liver cancer, and premature death. The disease is not widely…

Adipose Tissue, Metabolic Syndrome, and Non-Alcoholic Fatty Liver Disease – A Short Review

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease globally, and it is expected to rise even further as a result of the…

Overlapping Clinical Features Between NAFLD and Metabolic Syndrome in Children

Non-alcoholic fatty liver disease (NAFLD) is a cluster of pathological liver conditions of emerging importance in overweight and obese children.

Translation From Mice to Men: Are Dogs a Dodgy Intermediate?

Alternatives for liver transplantation in severe liver disease are urgently needed in view of the limited availability of donor livers.

News at Six: Hepatitis C Special

This Bristol Myers Squibb-sponsored symposium was chaired by Mark Thursz, who oversaw a novel news bulletin-themed symposium with sessions provided by a …

Transforming HCV Management

This Gilead-sponsored satellite symposium addressed the new and exciting advent of novel therapy in the field of hepatitis C by highlighting recent…

EMJ

Scientists Discover Potential New Target for Cancer Immunotherapy

Scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and…